Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma: A Network Meta-Analysis
2020 ◽
Vol 18
(4)
◽
pp. 244-251.e4
◽
2019 ◽
Vol 2
(6)
◽
pp. 708-715
◽
2014 ◽
Vol 40
(2)
◽
pp. 271-275
◽
Keyword(s):
2019 ◽
Vol 12
(4)
◽
pp. 334-338
◽
Keyword(s):
2015 ◽
Vol 16
(13)
◽
pp. 1915-1927
◽
2015 ◽
Vol 25
(5)
◽
pp. 395-401
◽
Keyword(s):